Niki BioSolutions, Inc. Additional Paid in Capital, Common Stock
Niki BioSolutions, Inc. (NIKI) had Additional Paid in Capital, Common Stock of $97.00 million as of 2025-12-31, per its S-4/A filed 2026-05-11.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2026-05-11
- 2025-12-31: Additional Paid in Capital, Common Stock $97.00M.
- 2025-09-30: Additional Paid in Capital, Common Stock $96.17M.
- 2025-06-30: Additional Paid in Capital, Common Stock $96.17M.
- 2024-12-31: Additional Paid in Capital, Common Stock $93.47M.
| Period end | Additional Paid in Capital, Common Stock |
|---|---|
| 2025-12-31 | $97.00M S-4/A · filed 2026-05-11 |
| 2025-09-30 | $96.17M 6-K · filed 2026-01-22 |
| 2025-06-30 | $96.17M 6-K · filed 2025-10-08 |
| 2024-12-31 | $93.47M S-4/A · filed 2026-05-11 |
| 2024-06-30 | $93.47M 6-K · filed 2024-12-20 |
| 2023-12-31 | $93.02M 6-K · filed 2025-10-08 |